Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774745 · ClinicalTrials.gov registry record · Phase 1
Blocking Mifepristone Action With Progesterone
A Phase 1 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03774745 is a Phase 1 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT03774745, a Phase 1 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Double-blind randomized trial to evaluate the potential impact of progesterone treatment on early pregnancies exposed to mifepristone.
Interventions
- DRUG Placebo oral capsule
- DRUG Mifepristone 200 MG
- DRUG micronized Progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-08-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03774745
The ClinicalTrials.gov registry entry for NCT03774745 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo oral capsule is the first listed.
NCT03774745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03774745 about?
NCT03774745 is a clinical study titled "Blocking Mifepristone Action With Progesterone". Double-blind randomized trial to evaluate the potential impact of progesterone treatment on early pregnancies exposed to mifepristone.
What is the current status of trial NCT03774745?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2019-02-11. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03774745?
The interventions under investigation include: Placebo oral capsule (DRUG), Mifepristone 200 MG (DRUG), micronized Progesterone (DRUG).
Who is sponsoring clinical trial NCT03774745?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.